{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T02:15:06Z","timestamp":1794449706747,"version":"4.9.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Bavarian Cancer Research Center"},{"name":"Klinikum der Universit\u00e4t M\u00fcnchen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Pulmonary metastasectomy (PM) is the most frequently performed local ablative therapy for leiomyosarcoma (LMS), synovial sarcoma (SyS), and undifferentiated pleomorphic sarcoma (UPS). This study aimed to assess surgical feasibility, outcome, and clinical prognostic factors, as well as the value of a peri-interventional systemic therapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This multicenter retrospective study enrolled 77 patients with LMS, SyS, or UPS who underwent first-time complete resection of isolated lung metastases between 2009 and 2021. Disease-free survival (DFS), overall survival (OS), and clinical prognostic factors were analyzed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>After the first PM, the median DFS was 7.4\u00a0months, and the median OS was 58.7\u00a0months. A maximal lesion diameter greater than 2\u00a0cm was associated with reduced DFS in both the univariable (hazard ratio [HR], 2.29; <jats:italic>p<\/jats:italic> = 0.006) and multivariable (HR, 2.60; <jats:italic>p<\/jats:italic> = 0.005) analyses. The univariable analysis identified a maximal lesion diameter greater than 2\u00a0cm as an adverse prognostic factor for OS (HR, 5.6; <jats:italic>p<\/jats:italic> &lt; 0.001), whereas a treatment-free interval longer than 12 months was associated with improved OS (HR, 0.42; <jats:italic>p<\/jats:italic> = 0.032). The addition of systemic therapy was associated with a trend toward improved DFS for patients with lesions larger than 2\u00a0cm (HR, 0.29; <jats:italic>p<\/jats:italic> = 0.063). Severe postoperative complications (grade \u2265IIIa) occurred in 2 % of the patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The size of resected lung metastases might be a more relevant prognostic factor than their number for patients with LMS, SyS, or UPS. For patients with lung metastases larger than 2 cm in maximal diameter, additional systemic therapy may be warranted.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1245\/s10434-025-17450-2","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T20:33:24Z","timestamp":1747254804000},"page":"5948-5956","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Does Size Outweigh Number in Predicting Survival After Pulmonary Metastasectomy for Soft Tissue Sarcoma? Insights from a Retrospective Multicenter Study"],"prefix":"10.1245","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9801-3530","authenticated-orcid":false,"given":"Anton","family":"Burkhard-Meier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Grube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vindi","family":"Jurinovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Agaimy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Albertsmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc M.","family":"Berclaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorit","family":"Di Gioia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Roland","family":"D\u00fcrr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00fcdiger","family":"von Eisenhart-Rothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chukwuka","family":"Eze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Fechner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Fey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinan E.","family":"G\u00fcler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith S.","family":"Hecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Hendricks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Keil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Knebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia R.","family":"Kov\u00e1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang G.","family":"Kunz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Lenze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisa M.","family":"L\u00f6rsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Meidenbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Mogler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina-Sophie","family":"Schmidt-Hegemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Semrau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wulf","family":"Sienel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Trepel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Waldschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Wiegering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars H.","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"key":"17450_CR1","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.mporth.2017.03.005","volume":"31","author":"TB Beckingsale","year":"2017","unstructured":"Beckingsale TB, Shaw C. Epidemiology of bone and soft-tissue sarcomas. Orthop Trauma. 2017;31:144\u201350. https:\/\/doi.org\/10.1016\/j.mporth.2017.03.005.","journal-title":"Orthop Trauma"},{"key":"17450_CR2","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1002\/CNCR.25538","volume":"117","author":"A Italiano","year":"2011","unstructured":"Italiano A, Mathoulin-Pelissier S, Le Cesne A, et al. Trends in survival for patients with metastatic soft-tissue sarcoma. Cancer. 2011;117:1049\u201354. https:\/\/doi.org\/10.1002\/CNCR.25538.","journal-title":"Cancer"},{"key":"17450_CR3","doi-asserted-by":"publisher","first-page":"108619","DOI":"10.1016\/j.ejso.2024.108619","volume":"50","author":"A Burkhard-Meier","year":"2024","unstructured":"Burkhard-Meier A, Grube M, Jurinovic V, et al. Unraveling the role of local ablative therapies for patients with metastatic soft tissue sarcoma: a retrospective multicenter study of the Bavarian university hospitals. Eur J Surg Oncol. 2024;50:108619. https:\/\/doi.org\/10.1016\/j.ejso.2024.108619.","journal-title":"Eur J Surg Oncol"},{"key":"17450_CR4","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.21037\/JTD-2019-PM-13","volume":"13","author":"D Stamenovic","year":"2021","unstructured":"Stamenovic D, Hohenberger P, Roessner E. Pulmonary metastasectomy in soft tissue sarcomas: a systematic review. J Thorac Dis. 2021;13:2649. https:\/\/doi.org\/10.21037\/JTD-2019-PM-13.","journal-title":"J Thorac Dis"},{"key":"17450_CR5","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1159\/000509519","volume":"43","author":"J Lochner","year":"2020","unstructured":"Lochner J, Menge F, Vassos N, Hohenberger P, Kasper B. Prognosis of patients with metastatic soft tissue sarcoma: advances in recent years. Oncol Res Treat. 2020;43:613\u20139. https:\/\/doi.org\/10.1159\/000509519.","journal-title":"Oncol Res Treat"},{"key":"17450_CR6","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1200\/JCO.1999.17.1.150","volume":"17","author":"M Van Glabbeke","year":"1999","unstructured":"Van Glabbeke M, van Oosterom AT, Oosterhuis JW, et al. Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2185 patients treated with anthracycline-containing first-line regimens: a European organization for research and treatment of cancer soft tissue and bone sarcoma group study. J Clin Oncol. 1999;17:150\u20137. https:\/\/doi.org\/10.1200\/JCO.1999.17.1.150.","journal-title":"J Clin Oncol"},{"key":"17450_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0022-5223(97)70397-0","volume":"113","author":"U Pastorino","year":"1997","unstructured":"Pastorino U, Buyse M, Friedel G, et al. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg. 1997;113:37\u201349. https:\/\/doi.org\/10.1016\/S0022-5223(97)70397-0.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"17450_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/BMJOPEN-2012-001736","author":"T Treasure","year":"2012","unstructured":"Treasure T, Fiorentino F, Scarci M, M\u00f8ller H, Utley M. Pulmonary metastasectomy for sarcoma: a systematic review of reported outcomes in the context of Thames cancer registry data. BMJ Open. 2012. https:\/\/doi.org\/10.1136\/BMJOPEN-2012-001736.","journal-title":"BMJ Open"},{"key":"17450_CR9","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1097\/JTO.0B013E3182106F5C","volume":"6","author":"JD Predina","year":"2011","unstructured":"Predina JD, Puc MM, Bergey MR, et al. Improved survival after pulmonary metastasectomy for soft tissue sarcoma. J Thorac Oncol. 2011;6:913\u20139. https:\/\/doi.org\/10.1097\/JTO.0B013E3182106F5C.","journal-title":"J Thorac Oncol"},{"key":"17450_CR10","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/JSO.25504","volume":"120","author":"R Nevala","year":"2019","unstructured":"Nevala R, J\u00e4\u00e4maa S, Tukiainen E, et al. Long-term results of surgical resection of lung metastases from soft tissue sarcoma: a single-center experience. J Surg Oncol. 2019;120:168\u201375. https:\/\/doi.org\/10.1002\/JSO.25504.","journal-title":"J Surg Oncol"},{"key":"17450_CR11","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1245\/S10434-022-11806-8","volume":"29","author":"T Stork","year":"2022","unstructured":"Stork T, Heged\u00fcs B, Guder W, et al. Prognostic factors for leiomyosarcoma with isolated metastases to the lungs: impact of metastasectomy. Ann Surg Oncol. 2022;29:4429. https:\/\/doi.org\/10.1245\/S10434-022-11806-8.","journal-title":"Ann Surg Oncol"},{"key":"17450_CR12","unstructured":"Armstrong SA, Balach T, Bishop AJ, et al. NCCN Guidelines Version 4.2024 Soft Tissue Sarcoma. 2024. https:\/\/www.nccn.org\/home\/member"},{"key":"17450_CR13","unstructured":"S3-Leitlinie Adulte Weichgewebesarkome."},{"key":"17450_CR14","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/J.ATHORACSUR.2011.05.052","volume":"92","author":"BM Burt","year":"2011","unstructured":"Burt BM, Ocejo S, Mery CM, et al. Repeated and aggressive pulmonary resections for leiomyosarcoma metastases extends survival. Ann Thorac Surg. 2011;92:1202\u20137. https:\/\/doi.org\/10.1016\/J.ATHORACSUR.2011.05.052.","journal-title":"Ann Thorac Surg"},{"key":"17450_CR15","doi-asserted-by":"publisher","first-page":"815","DOI":"10.6004\/JNCCN.2022.0035","volume":"20","author":"M von Mehren","year":"2022","unstructured":"von Mehren M, Kane JM, Agulnik M, et al. Soft tissue sarcoma, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Comp Cancer Ntwk. 2022;20:815\u201333. https:\/\/doi.org\/10.6004\/JNCCN.2022.0035.","journal-title":"J Natl Comp Cancer Ntwk"},{"key":"17450_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/ijc.2910330108","volume":"33","author":"M Trojani","year":"1984","unstructured":"Trojani M, Contesso G, Coindre JM, et al. Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer. 1984;33:37\u201342. https:\/\/doi.org\/10.1002\/ijc.2910330108.","journal-title":"Int J Cancer"},{"key":"17450_CR17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.32074\/1591-951X-213","volume":"113","author":"M Sbaraglia","year":"2021","unstructured":"Sbaraglia M, Bellan E, Dei Tos AP. The 2020 WHO classification of soft tissue tumours: news and perspectives. Pathologica. 2021;113:70\u201384. https:\/\/doi.org\/10.32074\/1591-951X-213.","journal-title":"Pathologica"},{"key":"17450_CR18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SLA.0B013E3181B13CA2","volume":"250","author":"PA Clavien","year":"2009","unstructured":"Clavien PA, Barkun J, De Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187\u201396. https:\/\/doi.org\/10.1097\/SLA.0B013E3181B13CA2.","journal-title":"Ann Surg"},{"key":"17450_CR19","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/J.EJCA.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228\u201347. https:\/\/doi.org\/10.1016\/J.EJCA.2008.10.026.","journal-title":"Eur J Cancer"},{"key":"17450_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S00432-024-06063-Z\/FIGURES\/6","volume":"151","author":"S Roohani","year":"2025","unstructured":"Roohani S, Handtke J, Hummedah K, et al. The sarcoma ring trial: a case-based analysis of inter-center agreement across 21 German-speaking sarcoma centers. J Cancer Res Clin Oncol. 2025;151:1\u201316. https:\/\/doi.org\/10.1007\/S00432-024-06063-Z\/FIGURES\/6.","journal-title":"J Cancer Res Clin Oncol"},{"key":"17450_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1749-8090-4-13\/TABLES\/6","volume":"4","author":"M Carballo","year":"2009","unstructured":"Carballo M, Maish MS, Jaroszewski DE, Holmes CE. Video-assisted thoracic surgery (VATS) as a safe alternative for the resection of pulmonary metastases: a retrospective cohort study. J Cardiothorac Surg. 2009;4:1\u201312. https:\/\/doi.org\/10.1186\/1749-8090-4-13\/TABLES\/6.","journal-title":"J Cardiothorac Surg"},{"key":"17450_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/CANCERS15174355","author":"K Grapatsas","year":"2023","unstructured":"Grapatsas K, D\u00f6rr F, Menghesha H, et al. New prognostic score (Essen score) to predict postoperative morbidity after resection of lung metastases. Cancers Basel. 2023. https:\/\/doi.org\/10.3390\/CANCERS15174355.","journal-title":"Cancers Basel"},{"key":"17450_CR23","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1097\/SLA.0B013E3181D0D211","volume":"251","author":"D Dindo","year":"2010","unstructured":"Dindo D, Hahnloser D, Clavien PA. Quality assessment in surgery: riding a lame horse. Ann Surg. 2010;251:766\u201371. https:\/\/doi.org\/10.1097\/SLA.0B013E3181D0D211.","journal-title":"Ann Surg"},{"key":"17450_CR24","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/J.CLON.2020.01.005","volume":"32","author":"C Tetta","year":"2020","unstructured":"Tetta C, Londero F, Micali LR, et al. Stereotactic body radiotherapy versus metastasectomy in patients with pulmonary metastases from soft tissue sarcoma. Clin Oncol (R Coll Radiol). 2020;32:303\u201315. https:\/\/doi.org\/10.1016\/J.CLON.2020.01.005.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"17450_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0158406","volume":"12","author":"O Derbel","year":"2017","unstructured":"Derbel O, Heudel PE, Cropet C, et al. Survival impact of centralization and clinical guidelines for soft tissue sarcoma: a prospective and exhaustive population-based cohort. PLoS One. 2017;12:e0158406. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0158406.","journal-title":"PLoS One"},{"key":"17450_CR26","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1093\/ANNONC\/MDX484","volume":"28","author":"JY Blay","year":"2017","unstructured":"Blay JY, Soibinet P, Penel N, et al. Improved survival using specialized multidisciplinary board in sarcoma patients. Ann Oncol. 2017;28:2852\u20139. https:\/\/doi.org\/10.1093\/ANNONC\/MDX484.","journal-title":"Ann Oncol"},{"key":"17450_CR27","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1016\/J.ATHORACSUR.2017.07.024","volume":"104","author":"NP Chudgar","year":"2017","unstructured":"Chudgar NP, Brennan MF, Tan KS, et al. Is Repeat pulmonary metastasectomy indicated for soft tissue sarcoma? Ann Thorac Surg. 2017;104:1837. https:\/\/doi.org\/10.1016\/J.ATHORACSUR.2017.07.024.","journal-title":"Ann Thorac Surg"},{"key":"17450_CR28","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1002\/IJC.31286","volume":"142","author":"LH Lindner","year":"2018","unstructured":"Lindner LH, Liti\u00e8re S, Sleijfer S, et al. Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first-line chemotherapy: an exploratory, retrospective analysis of the European organization for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC-STBSG). Int J Cancer. 2018;142:2610\u201320. https:\/\/doi.org\/10.1002\/IJC.31286.","journal-title":"Int J Cancer"},{"key":"17450_CR29","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/J.IJROBP.2011.08.036","volume":"83","author":"MT Milano","year":"2012","unstructured":"Milano MT, Katz AW, Zhang H, Okunieff P. Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study. Int J Radiat Oncol Biol Phys. 2012;83:878\u201386. https:\/\/doi.org\/10.1016\/J.IJROBP.2011.08.036.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"17450_CR30","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/J.EJCA.2016.02.002","volume":"58","author":"M Vlenterie","year":"2016","unstructured":"Vlenterie M, Liti\u00e8re S, Rizzo E, et al. Outcome of chemotherapy in advanced synovial sarcoma patients: review of 15 clinical trials from the European organisation for research and treatment of cancer soft tissue and bone sarcoma group; setting a new landmark for studies in this entity. Eur J Cancer. 2016;58:62\u201372. https:\/\/doi.org\/10.1016\/J.EJCA.2016.02.002.","journal-title":"Eur J Cancer"},{"key":"17450_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12916-017-0831-7\/FIGURES\/3","volume":"15","author":"M Savina","year":"2017","unstructured":"Savina M, Le Cesne A, Blay JY, et al. Patterns of care and outcomes of patients with METAstatic soft tissue SARComa in a real-life setting: the METASARC observational study. BMC Med. 2017;15:1\u201311. https:\/\/doi.org\/10.1186\/S12916-017-0831-7\/FIGURES\/3.","journal-title":"BMC Med"},{"key":"17450_CR32","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3182106f5c","author":"JD Predina","year":"2011","unstructured":"Predina JD, Puc MM, Bergey MR, et al. Improved survival after pulmonary metastasectomy for soft tissue sarcoma. J Thorac Oncol. 2011. https:\/\/doi.org\/10.1097\/JTO.0b013e3182106f5c.","journal-title":"J Thorac Oncol"},{"key":"17450_CR33","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3109\/17453679509002316","volume":"66","author":"PF Choong","year":"1995","unstructured":"Choong PF, Pritchard DJ, Rock MG, Sim FH, Frassica FJ. Survival after pulmonary metastasectomy in soft tissue sarcoma: prognostic factors in 214 patients. Acta Orthop Scand. 1995;66:561\u20138. https:\/\/doi.org\/10.3109\/17453679509002316.","journal-title":"Acta Orthop Scand"},{"key":"17450_CR34","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/J.CLON.2014.09.010","volume":"27","author":"AT Falk","year":"2015","unstructured":"Falk AT, Moureau-Zabotto L, Ouali M, et al. Effect on survival of local ablative treatment of metastases from sarcomas: a study of the French Sarcoma Group. Clin Oncol. 2015;27:48\u201355. https:\/\/doi.org\/10.1016\/J.CLON.2014.09.010.","journal-title":"Clin Oncol"},{"key":"17450_CR35","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1002\/cncr.23023","volume":"110","author":"RJ Canter","year":"2007","unstructured":"Canter RJ, Qin LX, Downey RJ, Brennan MF, Singer S, Maki RG. Perioperative chemotherapy in patients undergoing pulmonary resection for metastatic soft-tissue sarcoma of the extremity: a retrospective analysis. Cancer. 2007;110:2050\u201360. https:\/\/doi.org\/10.1002\/cncr.23023.","journal-title":"Cancer"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17450-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-17450-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17450-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T13:59:52Z","timestamp":1751464792000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-17450-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["17450"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-17450-2","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"assertion":[{"value":"27 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Johannes Waldschmidt is on the advisory board for Pharmamar.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}